title: Psoriasis onset with tocilizumab treatment for rheumatoid arthritis.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
authors.forename: Hélène
authors.initials: H
authors.lastname: Letho-Gyselinck
authors.forename: Xavier
authors.initials: X
authors.lastname: Guillot
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D012867:Skin / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C502936:tocilizumab